80
3
27
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10984 | DDR-TRK-1 | Discoidin Domain Receptor (DDR) | |
DDR-TRK-1 is a selective discoid domain receptor 1 (DDR1) inhibitor with IC50 value of 9.4 nM. DDR-TRK-1 also inhibits the TRK family. | |||
T31234 | DDR-TRK-1N | DDR-TRK1N,DDRTRK-1N,DDRTRK1N,DDR-TRK 1N,DDR TRK-1N | |
DDR-TRK-1N is a negative control for DDR-TRK-1. | |||
T34958 | TRK-380 | TAC301,TAC 301,TAC-301,TRK 380,TRK380 | |
TRK-380 (TAC-301) is an effective and selective β3-adrenergic receptor agonist. TRK-380 improves formalin-induced frequent urination in rats and carbachol-induced bladder contraction in dogs (a decrease of 37.6%). | |||
T40150 | Trk-IN-6 | ||
Trk-IN-6 shows excellent in vitro potency on a panel of TRK mutants ( IC 50 = 0.2-0.7 nM). | |||
T17169 | Trk-IN-4 | PF-6683324 isomer | Trk receptor |
Trk-IN-4 is an effective pan-Trk inhibitor in cell-based assays (IC50s: 1.9 nM, 2.6 nM, and 1.1 nM for TrkA, TrkB, and TrkC, respectively). | |||
T62429 | TRK-IN-14 | ||
TRK-IN-14 is a potent inhibitor of TRK. TRK-IN-13 has shown potential for TRK-related diseases. | |||
T61246 | TRK-IN-15 | ||
TRK-IN-15 (WO2012034091A1, compound X-55) is a highly effective inhibitor of TRK, a protein kinase with crucial involvement in the regulation of cellular growth, differentiation, and signal transduction. Offering signifi... | |||
T62093 | Trk-IN-11 | ||
Trk-IN-11 (Compound 14h) is a potent inhibitor of TRK, with IC50 values of 1.4 nM for TrkA and 1.8 nM for TrkA G595R. Trk-IN-11 has shown research potential in cancer diseases. | |||
T62806 | Trk-IN-9 | ||
Trk-IN-9 (Compound 12) is a potent inhibitor of TRK. trk-IN-9 inhibits the proliferation of Km-12 cell lines. trk-IN-9 induces apoptosis in a concentration-dependent manner. trk-IN-9 inhibits TRK phosphorylation and bloc... | |||
T62286 | TRK-IN-21 | ||
TRK-IN-21 (5n) is an orally active TRK inhibitor. TRK-IN-21 acts on TRKAWT (IC50: 0.3 nM), TRKAG667C (IC50: 2.3 nM), TRKAF589L (IC50: 0.4 nM) and TRKAG595 (IC50: 0.5 nM). TRK-IN-21 can be used to study cancer. | |||
T62095 | TRK-IN-19 | ||
TRK-IN-19 (Compound I-10 ) is a potent inhibitor of TRK with IC50 values of 1.1 nM for TRKA and 5.3 nM for TRKAG595R. TRK-IN-19 has shown potential research value in cancer disease. | |||
T61443 | Trk-IN-7 | ||
Trk-IN-7 (compound I-6) is a highly potent inhibitor of TRK, exhibiting IC50 values ranging from 0.25-10 nM for TRKA, TRKB, and TRKC, respectively. In addition, Trk-IN-7 demonstrates notable inhibition against EML4-ALK (... | |||
T61551 | Trk-IN-20 | ||
Trk-IN-20 is a 3-vinylindazole derivative compound that effectively inhibits the functions of Trk kinases. It accomplishes this by suppressing the phosphorylation of TrkA, TrkB, and TrkC, with IC50 values of 1.6 nM, 2.9 ... | |||
T62531 | TRK-IN-12 | ||
TRK-IN-12 (Compound 9e), a macrocyclic derivative, is a potent TRK inhibitor, with efficacy against TRK G595R (IC 50 = 13.1 nM). It demonstrates significant antiproliferative activity in the Ba/F3-LMNA-NTRK1 cell line (I... | |||
T62561 | TRK-IN-17 | ||
TRK-IN-17 is a potent inhibitor of TRK. Among them is promyosin-related kinase (Trks), a member of the receptor tyrosine kinase family, which is activated by neurotrophic factors. Neurotrophic factors are a group of solu... | |||
T63346 | TRK-IN-18 | ||
TRK-IN-18 is a potent inhibitor of TRK. Among them are promyosin-related kinases (Trks), a family of receptor tyrosine kinases activated by neurotrophic factors, a group of soluble growth factors containing nerve growth ... | |||
T28129 | Naltalimide | TRK-130,TRK 130,TRK130 | |
Naltalimide is a unique µ-opioid receptor partial agonist. Naltalimide also enhances the bladder storage function by modulating the afferent limb of the micturition reflex through µ-opioid receptors in the spinal cord. | |||
T64070 | Pan-Trk-IN-3 | ||
Pan-Trk-IN-3 is a potent, broad-spectrum inhibitor of Trk and its drug-resistant mutants, acting on TrkA (IC50: 2 nM), TrkB (IC50: 3 nM), TrkC (IC50: 2 nM), TrkAG595R (IC50: 21 nM), TrkAG667C (IC50: 26 nM), TrkAG667S (IC... | |||
T62428 | TRK-IN-13 | ||
TRK-IN-13 is a potent inhibitor of TRK. TRK-IN-13 has shown potential for the study of TRK-related diseases. | |||
T61872 | Trk-IN-10 | ||
Trk-IN-10 (Compound 14j) is a highly effective inhibitor of TRK, with an IC50 of 0.86 nM against TrkA and 6.92 nM against TrkA G595R. As an RTK, Trk plays a crucial role as a drug target in solid tumors. Trk-IN-10 (IC50 ... | |||
T61247 | TRK-IN-16 | ||
TRK-IN-16 (WO2012034091A1, compound X-21) is a highly effective TRK inhibitor, targeting protein kinases that are integral to regulating cell growth, differentiation, and various cellular signal transduction processes. ... | |||
T61712 | Trk-IN-8 | ||
Trk-IN-8, a powerful TRK inhibitor, demonstrates excellent potency against TRKAa, TRKA(G595R), and TRKC(G623R) with IC50 values of 0.42 nM, 0.89 nM, and 1.5 nM, respectively (WO2021115401A1, compound 3) [1]. | |||
T63076 | IHMT-TRK-284 | ||
IHMT-TRK-284 (Compound 34) is a potent, orally active type II TRK kinase inhibitor that acts on TRKA (IC50: 10.5 nM), TRKB (IC50: 0.7 nM), and TRKC (IC50: 2.6 nM). IHMT-TRK-284 exhibits good selectivity in the kinase gro... | |||
T78968 | TRK-IN-23 | Trk receptor | |
TRK-IN-23 (compound 24b) is a potent, orally active inhibitor of TRK with IC50s of 0.5 nM for TRKA, 9 nM for TRKC, 14 nM for TRKA G595R, 4.4 nM for TRKA F589L, and 4.8 nM for TRKA G667C. It induces apoptosis in Ba/F3-TRK... | |||
T79706 | TRK-IN-24 | Trk receptor | |
TRK-IN-24 (compound 10g) is a selective inhibitor of Trk receptors, effectively targeting TRKA, TRKC, and mutant forms TRKA G595R, TRKA G667C, and TRKA F589L, with IC50 values of 5.21, 4.51, 6.77, 1.42, and 6.13 nM, resp... | |||
T72931 | TRK/ALK-IN-1 | ||
TRK/ALK-IN-1 is a potent dual inhibitor of TRK and ALK, exhibiting good correlation between its enzymatic inhibition and anti-proliferative activities, with IC50 values of 2.2 nM for TRKA, 9.3 nM for ALK WT, and 38 nM fo... | |||
T72289 | Type II TRK inhibitor 1 | Trk receptor | |
Type II TRK Inhibitor 1 is a potent inhibitor targeting multiple tropomyosin receptor kinase (TRK) fusion protein variants as well as the wild type. It demonstrates notable antiproliferative effects on Ba/F3 cells expres... | |||
T73033 | TRK II-IN-1 | Trk receptor | |
TRK II-IN-1 is a potent type II inhibitor of tropomyosin receptor kinases (TRK), demonstrating inhibitory half-maximal inhibitory concentrations (IC50s) of 3.3, 6.4, 4.3, and 9.4 nM against TRKA, TRKB, TRKC, and the muta... | |||
T63475 | Pan-Trk-IN-2 | ||
Pan-Trk-IN-2 is a small molecule Trks inhibitor that exhibits promising antitumor effects. | |||
T14921 | CE-245677 | Tie-2 , Trk receptor | |
CE-245677 is a potent reversible inhibitor of Tie2 and TrkA/B kinases. With a cellular IC50s of 4.7 and 1 nM. | |||
T7568 | LM22A-4 | Trk receptor | |
LM22A-4 is a brain-derived neurotrophic factor (BDNF) mimetic and agonist of the receptor tropomyosin-related kinase B (TrkB; IC50 : 47 nM in a fluorescence anisotropy assay) | |||
T5635 | CH7057288 | Trk receptor | |
CH7057288 is an effective and selective TRK inhibitor with an IC50 value of 1.1 nM, 7.8 nM and 5.1 nM for TRKA, TRKB and TRKC, respectively. | |||
T14363 | AZ-23 | AZ 23,AZ23 | Trk receptor |
AZ-23 is an inhibitor of ATP-competitive and Trk kinase A/B/C. For TrkA, TrkB, FGFR1, Flt3, Ret, MuSk, Lck, the IC50s values are 2 nM, 8 nM, 24 nM, 52 nM, 55 nM, 84 nM, 99 nM, respectively. | |||
T6097 | GNF-5837 | GNF 5837 | Trk receptor , PDGFR , c-Kit |
GNF-5837 is a specific, and orally bioavailable pan-TRK inhibitor for TrkA/TrkB (IC50: 8/12 nM). | |||
T7435 | Selitrectinib | LOXO-195 | Trk receptor |
Selitrectinib (LOXO-195) is a potent and selective inhibitor of the receptor tyrosine kinases(TRK)( TrkA and TrkC with IC50s of 0.6 and <2.5 nM, respectively) | |||
T2359 | ANA-12 | ANA 12,ANA12 | Trk receptor |
ANA-12 is a potent and selective TrkB antagonist with anxiolytic and antidepressant activity in mice. | |||
T6052 | GW 441756 | Apoptosis , Raf , Trk receptor , CDK | |
GW 441756 is a specific Tropomyosin-related kinase A (TrkA) inhibitor with an IC50 value of 2 nM. | |||
T4496 | LM22B-10 | LM22B10 | ERK , Trk receptor , Akt |
LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor and can induce TrkB, TrkC, ERK and AKT activation in vitro and in vivo. | |||
T5995 | Larotrectinib | LOXO-101,ARRY-470 | Apoptosis , Trk receptor |
Larotrectinib (LOXO-101) is an orally administered inhibitor of the TRK kinase and is highly selective only for the TRK family of receptors(IC50s = 2-20 nM). | |||
T9123 | DS-1205 | TAM Receptor | |
DS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro an... | |||
T19649 | PF-06273340 | PF 6273340,PF 06273340,PF6273340,PF-6273340 | Trk receptor |
PF-06273340 is an effective, Selective, and Peripherally Restricted Pan-Trk inhibitor (IC50: Trk-A = 6 nM; Trk-B = 4 nM; Trk-C = 3 nM). PF-06273340 has low metabolic turnover in HLM and hHep is a good substrate for efflu... | |||
T8327 | ONO-7475 | Trk receptor , TAM Receptor | |
ONO-7475 is an inhibitor with high specificity for anexelekto and MER tyrosine kinase | |||
T4257 | Belizatinib | TSR-011 | Trk receptor , ALK |
Belizatinib (TSR-011) is an effective, oral and dual inhibitor of ALK (IC50: 0.7 nM, wild-type recombinant ALK) and TRKA, TRKB, and TRKC. | |||
T40019 | Thalidomide-5-NH2-CH2-COOH | Others | |
Thalidomide-5-NH2-CH2-COOH (compound 114) is a selective inhibitor of the protomyosin receptor kinase. It is a ligand for E3 ligase and has potential for studying one or more diseases. | |||
T4071 | Repotrectinib | TPX-0005,TPX 0005,TPX0005 | Trk receptor , ROS , Src , ALK , ROS Kinase |
Repotrectinib (TPX-0005) is a potent ALK/ROS1/TRK inhibitor, with IC50 of 1.01 nM, 5.3 nM, 1.08 nM and 1.26 nM for WT ALK, SRC, ALK L1196M and ALK G1202R, respectively. | |||
T2054 | Altiratinib | DCC-2701 | VEGFR , Tie-2 , FLT , Trk receptor , c-Met/HGFR |
Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist... | |||
T6712 | Tyrphostin AG 879 | AG 879 | Apoptosis , EGFR , Trk receptor , HER , PDGFR |
Tyrphostin AG 879 (AG 879) effectively inhibits HER2/ErbB2 (IC50: 1 μM), 100- and 500-fold higher selective to ErbB2 than EGFR and PDGFR. | |||
T3678 | Entrectinib | RXDX-101,NMS-E628 | Trk receptor , ROS , ALK , Autophagy , ROS Kinase |
Entrectinib (RXDX-101) is an inhibitor of TrkA (IC50: 1.7 nM), TrkB (IC50: 0.1 nM), and TrkC (IC50: 0.1 nM), as well as anaplastic lymphoma kinase (ALK; IC50: 1.6 nM) and C-ros oncogene 1 (ROS1; IC50: 0.2 nM). Entrectini... | |||
T0678 | Amitriptyline hydrochloride | Amitriptyline HCl,Tryptizol,Domical,Annoyltin | Trk receptor , Sigma receptor , 5-HT Receptor , Serotonin Transporter , Sodium Channel , Adrenergic Receptor , AChR , Norepinephrine , Histamine Receptor |
Amitriptyline hydrochloride (Annoyltin) is the hydrochloride salt of the tricyclic dibenzocycloheptadiene amitriptyline with antidepressant and antinociceptive activities. | |||
T6880 | Larotrectinib sulfate | LOXO-101 sulfate,Larotrectinib (LOXO-101) sulfate,Larotrectinib,LOXO-101 (sulfate),ARRY-470,ARRY-470 (sulfate) | Apoptosis , Trk receptor |
Larotrectinib sulfate (LOXO-101 sulfate) is an oral active and specific ATP-competitive inhibitor of tropomyosin receptor kinases (TRK). |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2816 | 7,8-Dihydroxyflavone | 7,8-DHF | Apoptosis , Trk receptor |
7,8-Dihydroxyflavone (7,8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves. | |||
T1354 | N-Acetyl-5-hydroxytryptamine | Normelatonin,O-Demethylmelatonin,N-Acetylserotonin | Trk receptor , Endogenous Metabolite |
N-Acetyl-5-hydroxytryptamine (O-Demethylmelatonin) , also known as Normelatonin, is the immediate precursor of melatonin. It is produced from serotonin by the enzyme aralkylamine N-acetyltransferase and is converted to m... | |||
T1716 | Echinacoside | Reactive Oxygen Species , Wnt/beta-catenin | |
Echinacoside is a natural polyphenolic compound with various kinds of pharmacological activities, such as anti-inflammatory, antioxidative, hepatoprotective, neuroprotective, nitric oxide radical-scavenging and vasodilat... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01084 | TrkA Protein, Human, Recombinant (His) | Human | HEK293 Cells |
TrkA Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 39.5 kDa and the accession number is P04629-1. | |||
TMPY-02231 | TrkB Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
TrkB Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 46 kDa and the accession number is P15209-2. | |||
TMPY-00751 | TrkB Protein, Human, Recombinant (His) | Human | HEK293 Cells |
TrkB Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 45.7 kDa and the accession number is Q16620-2. | |||
TMPK-00774 | TrkA Protein, Human, Recombinant (aa 33-417, His) | Human | HEK293 Cells |
TrkA, a tyrosine kinase receptor, is an essential component of the nerve growth factor (NGF) response pathway. The binding of NGF to the receptor induces receptor autophosphorylation and activation of intracellular signa... | |||
TMPY-01760 | TrkA Protein, Human, Recombinant (aa 194-413, His) | Human | HEK293 Cells |
TrkA Protein, Human, Recombinant (aa 194-413, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 26 kDa and the accession number is P04629-1. | |||
TMPY-01083 | TrkA Protein, Human, Recombinant (His & hFc) | Human | HEK293 Cells |
TrkA Protein, Human, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 66 kDa and the accession number is P04629-1. | |||
TMPY-01759 | TrkA Protein, Human, Recombinant (aa 285-413, His) | Human | E. coli |
TrkA Protein, Human, Recombinant (aa 285-413, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 15.1 kDa and the accession number is P04629-1. | |||
TMPY-03470 | TrkA Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 Cells |
TrkA Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 69.2 kDa and the accession number is Q3UFB7. | |||
TMPY-03536 | TrkA Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
TrkA Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.7 kDa and the accession number is Q3UFB7. | |||
TMPY-05509 | TrkB Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
TrkB Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 70.9 kDa and the accession number is Q16620-2. | |||
TMPY-02484 | SLITRK4 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
SLIT and NTRK-like family proteins 4 is a member of the SLIT and NTRK-like family. This protein is characterized as an integral membrane protein that has two leucine-rich repeat (LRR) domains and a carboxy-terminal domai... | |||
TMPY-00923 | SLITRK1 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
SLITRK1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 105-115 kDa and the accession number is Q96PX8. | |||
TMPY-03712 | TrkA Protein, Canine, Recombinant (His) | Canine | HEK293 Cells |
TrkA Protein, Canine, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 16.2 kDa and the accession number is XP_851619.3. | |||
TMPY-03063 | SLITRK6 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
SLITRK6 belongs to the SLITRK family. Members of this family share two conserved leucine-rich repeat domains in the extracellular domain. SLITRK6 contains 11 LRR (leucine-rich) repeats, 2 LRRCT domains and 2 LRRNT domain... | |||
TMPY-00945 | TrkC Protein, Human, Recombinant (His) | Human | HEK293 Cells |
TrkC Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 46.1 kDa and the accession number is Q16288-2. | |||
TMPY-04663 | TrkA Protein, Rabbit, Recombinant (His) | Rabbit | HEK293 Cells |
TrkA Protein, Rabbit, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.4 kDa and the accession number is XP_008262512.1. | |||
TMPY-02917 | TrkB Protein, Rat, Recombinant (hFc) | Rat | HEK293 Cells |
TrkB Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 71.5 kDa and the accession number is Q63604-1. | |||
TMPY-00922 | SLITRK1 Protein, Human, Recombinant (His & hFc) | Human | HEK293 Cells |
SLITRK1 Protein, Human, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 95 kDa and the accession number is Q96PX8. | |||
TMPY-03635 | TrkB Protein, Canine, Recombinant (His) | Canine | HEK293 Cells |
TrkB Protein, Canine, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.7 kDa and the accession number is XP_541264.2. | |||
TMPY-03162 | TrkB Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
TrkB Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 47.1 kDa and the accession number is Q63604. | |||
TMPY-01223 | TrkC Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
TrkC Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 46.1 kDa and the accession number is Q6VNS1-1. | |||
TMPY-06967 | TrkA Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells |
TrkA Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.95 kDa and the accession number is XP_005541454.3. | |||
TMPY-03560 | TrkA Protein, Rat, Recombinant (hFc) | Rat | HEK293 Cells |
TrkA Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 69.2 kDa and the accession number is P35739. | |||
TMPY-04285 | TrkA Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
TrkA Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.7 kDa and the accession number is A6J617. | |||
TMPY-00228 | TrkB Protein, Canine, Recombinant (hFc) | Canine | HEK293 Cells |
TrkB Protein, Canine, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 71.2 kDa and the accession number is XP_541264.2. | |||
TMPY-00944 | TrkC Protein, Human, Recombinant (His & hFc) | Human | HEK293 Cells |
TrkC Protein, Human, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 72.5 kDa and the accession number is Q16288-2. | |||
TMPY-03711 | TrkA Protein, Canine, Recombinant (hFc) | Canine | HEK293 Cells |
TrkA Protein, Canine, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 42.3 kDa and the accession number is XP_851619.3. |